药物对比
Vildagliptin vs Pramlintide
比较Vildagliptin（治疗2型糖尿病的口服DPP-4抑制剂）与Pramlintide（注射用胰淀素类似物）。Pramlintide与胰岛素联用带有低血糖黑框警告。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes or those using mealtime insulin comparing an oral DPP-4 inhibitor to an injectable amylin analog adjunct therapy.
结论
The preferred option between Vildagliptin and Pramlintide depends on insulin requirements, injection preference, and hypoglycemia risk rather than one being inherently better.
全部药物对比